Gefitinib effectiveness in an head and neck squamous cell carcinoma in vitro model

被引：0
|
作者：
Sebastian, Sinto
Azzariti, Amalia
Porcelli, Letizia
Simone, Grazia M.
Tommasino, Massimo
Paradiso, Angelo
机构：
[1] Natl Canc Inst, Bari, Italy
[2] Int Agcy Res Canc Ctr IARC, Infect & Canc Biol Grp, Lyon, France
来源：
CANCER RESEARCH | 2006年 / 66卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4749
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase II study of 250 mg gefitinib in advanced squamous cell carcinoma of the head and neck (SCCHN).
    Kane, MA
    Cohen, E
    List, M
    Mehrotra, B
    Gustin, D
    Mauer, A
    Cella, D
    Vokes, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 509S - 509S
  • [32] A phase II trial of ZD 1839 (Gefitinib) for advanced cutaneous squamous cell carcinoma of head and neck
    Weber, R. S.
    Glisson, B. S.
    Taylor, S. A.
    Hanna, E. Y.
    El-Naggar, A. K.
    Chambers, M. S.
    ORAL ONCOLOGY, 2009, : 190 - 190
  • [33] Phase I study of gefitinib plus celecoxib in recurrent or metastatic squamous cell carcinoma of the head and neck
    Wirth, LJ
    Haddad, RI
    Lindeman, NI
    Zhao, XJ
    Lee, JC
    Joshi, VA
    Norris, CM
    Posner, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (28) : 6976 - 6981
  • [34] A MURINE MODEL FOR THE IMMUNOTHERAPY OF HEAD AND NECK SQUAMOUS-CELL CARCINOMA
    HIER, MP
    BLACK, MJ
    SHENOUDA, G
    SADEGHI, N
    KARP, SE
    LARYNGOSCOPE, 1995, 105 (10): : 1077 - 1080
  • [35] Biomarkers of squamous cell carcinoma of the head and neck
    Kim, J
    Shin, DM
    HISTOLOGY AND HISTOPATHOLOGY, 1997, 12 (01) : 205 - 218
  • [36] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Moskovitz, Jessica
    Moy, Jennifer
    Ferris, Robert L.
    CURRENT ONCOLOGY REPORTS, 2018, 20 (02)
  • [37] Characterization of a new rat model of head and neck squamous cell carcinoma
    Aubry, Karine
    Paraf, Francois
    Monteil, Jacques
    Bessede, Jean Pierre
    Rigaud, Michel
    IN VIVO, 2008, 22 (04): : 403 - 408
  • [38] Immunotherapy for head and neck squamous cell carcinoma
    Fuereder T.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 66 - 69
  • [39] Afatinib in squamous cell carcinoma of the head and neck
    Specenier, Pol
    Vermorken, Jan
    EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (09) : 1295 - 1301
  • [40] Immunotherapy for Head and Neck Squamous Cell Carcinoma
    Hoesli R.C.
    Moyer J.S.
    Current Oral Health Reports, 2016, 3 (2) : 74 - 81
12345